The Growth of Regional Gene Therapy Hubs and the Globalization of Clinical Trials within the Adeno-associated Virus Vector-based Gene Therapy Sector for Late 2025
The geography of the AAV sector is shifting in late 2025, with the rise of major "Gene Therapy Hubs" in India, China, and the Middle East. These regions are no longer just "manufacturing sites"; they are now leading the world in clinical trial recruitment and localized innovation. By conducting trials in diverse global populations, companies are ensuring that their therapies are safe and...
0 Comments 0 Shares 20 Views 0 Reviews
Sponsored
google.com, pub-3499622606299644, DIRECT, f08c47fec0942fa0